Protalix BioTherapeutics Inc. (DE) (PLX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Protalix BioTherapeutics Inc. (DE), updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$2.59
+2.37% today
Market cap
$204M
Overall quality
—
Kronos AI 30-day
−3.5%
2 of 8 simulated paths end higher
Protalix BioTherapeutics Inc. (DE) (PLX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $204M. It trades at $2.59, up 2.37% today. 1 analysts' average target of $12.00 implies +363.3% from today's price. Kronos AI's 30-day forecast is −3.5% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $12.00 |
| Low – high | $12.00 – $12.00 |
| Analysts | 1 |
| Upside to average | +363.3% |
Kronos AI 30-day forecast
| Expected close | $2.44 (−3.5%) |
| Likely range | −6.9% … +2.0% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.